8-K/A XBRL

FORM 8-K/A

Company: Outlook Therapeutics, Inc.
Filed: April 3, 2023
Period of Report: March 30, 2023
Accession Number: 0001104659-23-040901

View Document ↗ View on SEC.gov ↗